Takeda allies with Frazier to spin out late-phase norovirus vaccinei
Takeda allies with Frazier to spin out late-phase norovirus vaccinei [...]
Ardelyx’s FDA rejection points to long path back for CKD drug
Ardelyx’s FDA rejection points to long path back for CKD [...]
Surprise! Pfizer jumps the queue and leaps into RSV vax contention as COVID helps turbo charge work
Surprise! Pfizer jumps the queue and leaps into RSV vax [...]
Rakuten Medical rakes in $166M series D following drug-device combo’s approval in Japan
Rakuten Medical rakes in $166M series D following drug-device combo’s [...]
People of color want to participate in Alzheimer’s research. The NIA has a new tool to make it happen
People of color want to participate in Alzheimer’s research. The [...]
Immune system protein prompts obese mice to ‘sweat’ out fat, inspiring new treatment target
Immune system protein prompts obese mice to ‘sweat’ out fat, [...]
AstraZeneca drops Dupixent rival tezepelumab in atopic dermatitis, as asthma focus sharpens
AstraZeneca drops Dupixent rival tezepelumab in atopic dermatitis, as asthma [...]
Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics
Ipsen pens early-stage, $14.5M programmed cell death cancer deal with [...]
GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again in lung cancer
GSK culls phase 2 RSV vaccine in kids, as feladilimab [...]
Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B
Gilead-partnered Teneobio and its next-gen cancer work snapped up by [...]